TITLE

Stem Cells, New Agency Await Illinois Lawmakers' Consideration

AUTHOR(S)
Shields, Yvette
PUB. DATE
March 2005
SOURCE
Bond Buyer;3/2/2005, Vol. 351 Issue 32081, p3
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article informs that while Illinois lawmakers are still digesting a partially bond-financed $9.4 billion capital budget, several other substantial new bonding proposals also await their attention, including a $1 billion borrowing program for stem cell research and the creation of a new southeastern economic development authority. A public rally is scheduled for today on the stem cell borrowing plan floated late last year by Comptroller Daniel Hynes and formally introduced as legislation by last week. Under the plan, the state would create the Illinois Regenerative Medicine Institute to foster stem-cell research with grants that would come from $1 billion of bonds.
ACCESSION #
16283805

 

Related Articles

  • Still strict on stem cells. Wadman, Meredith // Nature;4/23/2009, Vol. 458 Issue 7241, p950 

    The article discusses provisional rules for federally-funded stem-cell research issued by the U.S. National Institutes of Health (NIH). The reaction among researchers was mixed as critics believe they are too restrictive regarding use of embryos created for research using "in vitro"...

  • Calif. Stem-Cell Institute Might Issue Bans As Litigation Impedes Bonds. Saskal, Rich // Bond Buyer;5/10/2005, Vol. 352 Issue 32129, p36 

    The article reports that California will explore the use of bond anticipation notes to provide startup financing for a stem-cell medical research program created in 2004 in a voter-approved $3 billion bond authorization. The Bans would provide initial financing for the California Institute for...

  • Stem-Cell Bonds May Get Push. Saskal, Rich // Bond Buyer;3/31/2005, Vol. 351 Issue 32101, p1 

    This article reports that the board that oversees California's $3 billion stem-cell bond venture may take the first formal steps to its initial debt issue. In November, the state's voters authorized $3 billion of general obligation bonds for stem-cell medical research and created the California...

  • UK Bill Would Clear Way For Interspecies Research. Moran, Nuala // BioWorld International;5/23/2007, Vol. 12 Issue 21, p1 

    The article reports on the passage of the Human Tissue and Embryos bill in Great Britain. The law is expected to liberalize embryonic stem cell research in Great Britain to allow the creation of animal/human hybrid embryos, in which the nucleus of an adult human cells is inserted into the...

  • STEM CELL POLICY: WHERE DO WE DRAW THE LINES? Knowles, Lori P. // New England Law Review;Spring2005, Vol. 39 Issue 3, p623 

    Focuses on policies with regard to human embryonic stem cells (hESC) research. Information on three areas wherein concerns about the acceptability and permissibility of hESC research fall; Overview of a number of stem cell policy options; List of countries that have enacted embryo research...

  • State legislators champion funding for stem-cell research. Weillgreenberg, Elizabeth // New York Amsterdam News;1/20/2005, Vol. 96 Issue 4, p26 

    This article presents information related to initiatives undertaken by New York legislators to conduct stem cell research. In hopes of helping those suffering from Parkinson's, juvenile diabetes and AIDS, New York legislators are trying to fill the void left by the federal government's...

  • Australian stem cell researchers call for less regulatory red tape.  // Australian Life Scientist;3/2/2011, p1 

    The licensing system for creating stem cells is preventing potentially life saving research and should be streamlined, say Australian stem cell researchers.

  • European court's ban on stem cell patents could mean research goes abroad, say scientists. Dyer, Clare // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;10/22/2011, Vol. 343 Issue 7828, p813 

    No abstract available.

  • With Lawsuit Dead, California Is Free to Sell Stem Cell Bonds. Saskal, Rich // Bond Buyer;5/18/2007, Vol. 360 Issue 32632, p40 

    The article reports on the sale of bonds to finance medical research using stem cells as soon as it is practical after the demise of a lawsuit that had delayed them for more than two years in California. Voters have approved Proposition 71 authorizing $3 billion of general obligation bonds for...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics